The Spatial Omics Market is estimated to be valued at US$ 267 million in 2022 and is expected to exhibit a CAGR of 9.4% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Spatial omics refers to techniques that enable the mapping of various molecular attributes such as DNA, RNA, proteins, and metabolites to spatial locations within a tissue sample. Spatial omics integrated multi-omics data and spatial information to interpret the cellular and molecular heterogeneity of tissues and whole organs. It finds wide applications in research related to cancer, neuroscience, immunology, and developmental biology.
Market Dynamics:
Advancements in spatial techniques: Technological advancements are being made to improve the resolution, throughput, and multiplexing capabilities of spatial omics techniques such as spatial transcriptomics, spatial proteomics, and spatially resolved metabolomics. This is driving higher adoption of spatial omics approaches among research organizations and pharma companies.
Rising adoption of multi-omics analysis: Researchers are increasingly looking to integrate multi-omics data at single-cell and spatial levels to gain a more comprehensive understanding of cell types and cell state changes. The ability of spatial omics techniques to simultaneously analyze the genomics, epigenomics, transcriptomics, proteomics, and metabolomics landscapes is driving their demand. This is expected to significantly contribute to the growth of the spatial omics market during the forecast period.
Growing applications in immunology, neuroscience and cancer research is expected to boost the spatial omics market. Adoption across developing regions owing to increasing research focus on precision medicine presents lucrative opportunities. Integration of spatial omics with other -omics techniques and artificial intelligence will further expand the scope of applications.
Threats: Explain two threats two sentence explanation;
Stiff competition among existing players may lead to pricing pressures. Strict regulatory environment for in vitro diagnostic use of this technique poses threats.
Key Takeaways
The global Spatial Omics Market is expected to witness high growth, exhibiting CAGR of 9.4% over the forecast period, due to increasing R&D investments by pharma and biotech companies for drug discovery. The United States dominates the global spatial omics market with the largest revenue share. Factors such as presence of key players, rising research activities for developing spatial omics based precision medicines and growing biotech industry drive the growth. The Asia Pacific spatial omics market is poised to exhibit the highest growth rate during the forecast period owing to rising healthcare expenditure, increasing research focus and favorable government funding.
Key players operating in the spatial omics market are 10x Genomics, Akoya Bioscience Inc., Biognosys AG, BioSpyder Technologies, Bio-Techne, Bruker, Brooks Automation Inc., Danaher Corporation, Diagenode. 10x Genomics dominates the market with its Visium platform for spatial transcriptomics. The company is focused on expanding applications and launching new products to strengthen its market position. Other major players adopt strategies such as partnerships, acquisitions and geographic expansions to gain competitive edge.
